KIT and anaphylaxis: Nevertheless, screening for underlying cMCD (by peripheral blood KIT p.D816V variant detection using highly sensitive molecular methods) is indicated in all patients with severe anaphylaxis, especially HVA [12,13], to avoid unnecessary deaths.